U.S. Electric Utilities Stock News

Steel Dynamics (STLD) has drawn investor attention after recent share moves, with the stock last closing at $172.74. That price sits alongside an indicated intrinsic discount of 50% based on one valuation estimate. See our latest analysis for Steel Dynamics. Recent trading reflects steady interest, with a 17.9% 90 day share price return and a 4.6% 30 day share price return. The 1 year total shareholder return of 46.3% points to momentum that is still intact, despite a slightly negative year...

BlackRock stock at a glance after recent performance BlackRock (BLK) has seen mixed share performance recently, with a 0.7% decline over the past day, a 2.7% gain over the past week, and a 4.5% decline over the past 3 months. See our latest analysis for BlackRock. At a share price of $1,112.28, BlackRock’s mixed recent share price returns, including a 3.7% 1 month gain alongside a 4.5% 3 month decline, contrast with a stronger 1 year total shareholder return of 15.7%. This suggests near term...

BioNTech (NasdaqGS:BNTX) is back in focus after Pfizer and the company reported initial COVID-19 vaccine data suggesting over 90% effectiveness in preventing infection, while scientists highlighted unanswered questions about long term protection. See our latest analysis for BioNTech. That vaccine announcement lands against a mixed backdrop, with the share price at $98.09 after a 1 day share price return of 1.28% and a 90 day share price return decline of 7.71%, while the 1 year total...

Why the envudeucitinib data matters for Alumis shareholders Alumis (ALMS) reported that its Phase 3 ONWARD1 and ONWARD2 trials for envudeucitinib in moderate to severe plaque psoriasis met all primary and secondary endpoints with high statistical significance, a key clinical milestone for the company. The company also said it plans to file a New Drug Application with the U.S. Food and Drug Administration in the second half of the year, which would move envudeucitinib from late stage...

DayOne Data Centers, backed by GDS Holdings, recently secured over US$2.00 billion in Series C equity financing led by existing investor Coatue and other global institutions to accelerate its build-out of AI-ready hyperscale campuses across Europe and the Asia-Pacific region, including Finland, Thailand, Japan and Hong Kong. This deal underlines GDS Holdings’ growing role in supporting sustainable, large-scale digital infrastructure beyond China, potentially broadening its growth and...

If you are wondering whether Deckers Outdoor's current share price reflects its true worth, you are not alone. This article is built to focus squarely on what you might be paying for versus what you are getting. The stock last closed at US$107.46, with returns of 2.3% over 7 days, 7.8% over 30 days, 0.6% year to date, a 47.6% decline over 1 year, and gains of 58.8% over 3 years and 93.8% over 5 years. Taken together, this gives a mixed picture for investors thinking about risk and...

United Parcel Service recently reported quarterly results that exceeded earnings and margin expectations, reflecting early benefits from its Efficiency Reimagined turnaround plan, including facility closures, cost cuts, and a shift away from lower-margin Amazon volumes. These actions, alongside a high forward dividend yield and progress in higher-margin areas like healthcare logistics, are reshaping UPS’s risk-reward profile for income-focused and long-term investors. We’ll now examine how...

If you are wondering whether Ford Motor's current share price lines up with its true worth, you are not alone. Over the last year, the stock shows a 51.9% return, with 4.3% over 7 days, 5.9% over 30 days and 3.4% year to date, which has naturally changed how some investors think about its risk and potential. Recent coverage has focused on Ford Motor's role in the U.S. auto market and investor interest in its longer term transition plans, with headlines often linking the share price to...

Event driven interest in AES stock AES (AES) is back on investors' radar after the company announced a new energy collaboration along with a positive analyst upgrade, both tied to its longer term push into renewable power projects. See our latest analysis for AES. Those announcements come after a mixed stretch for investors, with AES’s share price at $14.90 and a 1 month share price return of 7.04% but a 3 year total shareholder return of 37.56% decline. Recent gains hint at improving...

In recent months, Enovix reported Q3 2025 revenue of US$8.0 million, reflecting very large year-on-year growth, while its Chief Accounting Officer Kristina Truong sold shares to cover tax obligations from restricted stock units. At the same time, the company’s push to prove large-scale manufacturing of its silicon-anode batteries, alongside ongoing execution challenges and production delays, has become a central focus for investors assessing its progress. Next, we’ll examine how Enovix’s...

Datavault AI recently announced a nationwide rollout of its SanQtum quantum-secure private edge cloud across 100 U.S. cities in 2026, alongside a series of tokenized autograph initiatives with NFL players tied to Dream Bowl Meme Coin collectibles and upcoming NIL and digital exchanges. By marrying large-scale, cybersecure edge infrastructure with blockchain-based sports memorabilia and data tokenization, the company is positioning its technology at the crossroads of AI-powered data...

FactSet Research Systems (FDS) opened fiscal Q1 2026 with revenue of US$607.6 million and basic EPS of US$4.08, setting the tone for another period where profit trends are front and center for investors. Over the past six quarters, the company has seen revenue move from US$562.2 million in Q4 2024 to US$607.6 million in Q1 2026, while basic EPS increased from US$2.35 to just over US$4.00, with trailing twelve month EPS at US$15.87. With net profit margins running in the mid 20% range over the...

If you are wondering whether Virtu Financial's current share price still reflects good value, it helps to step back and look at what the recent returns and our valuation checks are really saying. The stock last closed at US$33.17, with a 7 day return of a 2.4% decline, a 30 day return of a 6.2% decline, a 1 year return of a 6.0% decline, and a 72.3% return over 3 years and a 65.2% return over 5 years. These mixed returns sit against an ongoing flow of market commentary about liquidity...

ARK Invest recently expanded its position in Beam Therapeutics (BEAM), adding more than 195,000 shares as it leans further into precision genetic medicines and base-editing approaches to address serious inherited diseases. See our latest analysis for Beam Therapeutics. The ARK purchase comes as Beam Therapeutics trades at US$28.34, with a 1 day share price return of 5.59% and a year to date share price return of 4.42%. The 1 year total shareholder return of 4.65% sits against a 5 year total...

CrowdStrike, alongside Amazon Web Services and NVIDIA, has already launched its 2026 Cybersecurity Startup Accelerator, selecting 35 AI-focused cloud security startups for an eight-week program that offers mentorship, technical support, funding opportunities, and a final pitch day at the RSA Conference. This accelerator, together with CrowdStrike’s work on securing AI agents and expanding its Falcon platform, underlines how the company is positioning itself at the center of AI-driven...

In early January 2026, Western Digital reported surging demand for its high-capacity hard drives used in AI and cloud data centers, following its split from the flash business and sharpened focus on enterprise and hyperscale customers. This shift, reinforced by its addition to the Nasdaq-100 and constrained supply for AI-optimized storage, is increasingly positioning Western Digital as a crucial infrastructure provider for the generative AI buildout. We’ll now examine how Western Digital’s...

What is moving Venture Global right now? With no single headline event in play, Venture Global (VG) is drawing attention mainly because its share price has moved differently over the past week, month and past 3 months, prompting fresh interest from value focused investors. See our latest analysis for Venture Global. At a share price of $6.96, Venture Global’s recent moves include a 1 day share price return of 1.90%, a 30 day share price return of 2.05%, and a 90 day share price return showing...

If you are wondering whether Texas Instruments is reasonably priced at its current level, this overview will help you size up the stock before you think about your next move. The shares recently closed at US$192.08, with returns of 9.5% over 7 days, 5.2% over 30 days, 8.2% year to date, 3.2% over 1 year, 17.9% over 3 years and 28.5% over 5 years. Recent coverage around Texas Instruments has focused on its position in analog and embedded semiconductors and how investors view that exposure...

In early January 2026, Wave Life Sciences announced that CEO Paul Bolno would present at the 44th Annual J.P. Morgan Healthcare Conference, as investors watch closely for early 2026 follow‑up data on its obesity candidate WVE-007 after a single-dose trial cohort showed a 9.4% visceral fat reduction with lean mass increasing. The company also recently raised about US$402.5 million through an equity offering, extending its cash runway into late 2028 and sharpening attention on whether...

Alexandria Real Estate Equities (ARE) is back in focus after multiple securities class action lawsuits linked to its Long Island City property, a substantial real estate impairment charge, and missed third quarter 2025 financial expectations. See our latest analysis for Alexandria Real Estate Equities. The legal overhang and asset impairment news come amid a sharp reset in investor sentiment, with a 30 day share price return of 15.17% following a 90 day share price decline of 30.36% and a 1...

Recent commentary has highlighted Monster Beverage’s rapid historical growth, strong cultural resonance on platforms like TikTok and YouTube, and broad global retail presence, underscoring its position as a leading energy drink producer. What stands out is how Monster’s lifestyle-driven marketing and extensive zero‑sugar and flavor range have turned the brand into a durable cultural fixture, particularly among younger consumers. Next, we’ll examine how Monster’s powerful cultural resonance...

Barclays’ recent upgrade of Centene (CNC) to Overweight, supported by a detailed view of its Affordable Care Act business and margin potential, has pushed the stock into sharper focus for health insurance investors. See our latest analysis for Centene. The recent Barclays upgrade comes after a sharp rebound in sentiment, with a 30 day share price return of 19.30% and a 90 day share price return of 18.96%. This contrasts with a 1 year total shareholder return decline of 26.94%, so momentum has...

If you are wondering whether PENN Entertainment is a bargain or a value trap at around US$14.81, you are not alone. The numbers offer some clear signals to examine. The share price return is 0.2% over the last 7 days and 7.2% over the last 30 days, while year to date the return is a 0.3% decline. Over 1 year the return is a 22.1% decline, and over 3 and 5 years the returns are 52.7% decline and 86.0% decline respectively. Recent market attention on PENN Entertainment has been shaped by...

Roivant Sciences (ROIV) is back in focus after recent analyst commentary related to its lead drug candidate, brepocitinib. The company now has accelerated timelines along with updated expectations around costs and future profitability. See our latest analysis for Roivant Sciences. Roivant’s shares have been volatile around the recent brepocitinib updates, with the latest share price at US$21.30, a 90 day share price return of 32.88% and a 1 year total shareholder return of 84.90%. This...